1. Home
  2. EHTH vs ANVS Comparison

EHTH vs ANVS Comparison

Compare EHTH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.59

Market Cap

104.0M

Sector

Finance

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.84

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
ANVS
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
69.1M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
EHTH
ANVS
Price
$1.59
$1.84
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$3.33
$13.50
AVG Volume (30 Days)
314.4K
1.2M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
39.39
EPS
N/A
N/A
Revenue
$251,395,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$1.54
52 Week High
$5.89
$5.50

Technical Indicators

Market Signals
Indicator
EHTH
ANVS
Relative Strength Index (RSI) 41.01 39.83
Support Level $1.21 $1.79
Resistance Level $1.72 $2.38
Average True Range (ATR) 0.09 0.16
MACD -0.03 -0.03
Stochastic Oscillator 21.92 8.87

Price Performance

Historical Comparison
EHTH
ANVS

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: